{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:35:38Z","timestamp":1785332138833,"version":"3.55.0"},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,19]]},"DOI":"10.1515\/cclm-2014-0097","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T17:05:28Z","timestamp":1412096728000},"source":"Crossref","is-referenced-by-count":24,"title":["The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer"],"prefix":"10.1515","volume":"52","author":[{"given":"Federica","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Panteghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref91","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2004.040659","article-title":"de Biological variation of tumor markers and its application in the detection of disease progression in patients with non - small cell lung cancer","volume":"22","author":"Trap\u00e9","year":"2005","journal-title":"Clin Chem"},{"key":"ref511","first-page":"125","article-title":"Value of CA as a marker of ovarian cancer","volume":"13","author":"Markowska","year":"1992","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref481","first-page":"190","article-title":"Diagnostics GmbH reagent Ref","author":"Roche","year":"2013"},{"key":"ref21","article-title":"National Institute for Health and Clinical Excellence Guidance Ovarian cancer : the recognition and initial management of ovarian cancer National Collaborating Centre for Cardiff National Collaborating Centre for","author":"NICE","year":"2011","journal-title":"Cancer Cancer"},{"key":"ref211","first-page":"1","article-title":"Desirable specifications for total error imprecision and bias derived from intra - and inter - individual biologic variation Available from http www westgard com biodatabase htm format phocapdf Accessed","author":"January","year":"2014"},{"key":"ref41","first-page":"4","article-title":"Serum human epididymis protein vs carbohydrate antigen for ovarian cancer diagnosis : a systematic","author":"Ferraro","year":"2013","journal-title":"review J Clin Pathol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/000456329102800301","article-title":"PH The importance of imprecision","volume":"28","author":"Fraser","year":"1991","journal-title":"Ann Clin Biochem"},{"key":"ref441","first-page":"166","article-title":"Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women","author":"Tamimi","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref551","first-page":"125","article-title":"The effect of the menstrual cycle on serum CA levels a population study","author":"Grover","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"ref111","first-page":"382","article-title":"Need for a more correct estimate of biological variation values","author":"Franzini","year":"2011","journal-title":"Clin"},{"key":"ref101","first-page":"419","article-title":"Estimate of intraindividual variability of reactive protein a challenging issue","author":"Braga","year":"2013","journal-title":"Clin Chim Acta"},{"key":"ref171","first-page":"190","article-title":"Diagnostics GmbH reagent Ref","author":"Roche","year":"2013"},{"key":"ref431","first-page":"413","article-title":"Biologic variability of reactive protein is the available information reliable","author":"Braga","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref161","first-page":"170","article-title":"Imprecision of tumour biomarker measurements on Modular platform fulfills desirable goals derived from biological variation","author":"Dolci","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"ref601","first-page":"125","article-title":"Reference ranges for HE CA in a large Asian population by automated assays and diagnostic performances for ovarian cancer","author":"Park","year":"2012","journal-title":"Int J Cancer"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.2012.43.6691","article-title":"CD Longitudinal screening algorithm that incorporates change over time in CA levels identifies ovarian cancer earlier than a single - threshold rule","volume":"31","author":"Drescher","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref411","first-page":"419","article-title":"Estimate of intraindividual variability of reactive protein a challenging issue","author":"Braga","year":"2013","journal-title":"Clin Chim Acta"},{"key":"ref381","first-page":"89","article-title":"Objective interpretation of results for tumour marker Allied","author":"Browning","year":"1990","journal-title":"J Nucl Med Sci"},{"key":"ref471","first-page":"170","article-title":"Imprecision of tumour biomarker measurements on Modular platform fulfills desirable goals derived from biological variation","author":"Dolci","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/CCLM.1998.024","article-title":"Need for correct estimates of biological variation : the example of reactive protein","author":"Franzini","year":"1998","journal-title":"Clin Chem Lab Med"},{"key":"ref421","first-page":"382","article-title":"Need for a more correct estimate of biological variation values","author":"Franzini","year":"2011","journal-title":"Clin"},{"key":"ref201","first-page":"125","article-title":"Value of CA as a marker of ovarian cancer","volume":"13","author":"Markowska","year":"1992","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref561","first-page":"6391","article-title":"Human epididymis protein reference intervals in a multiethnic Asian women population Asian","volume":"13","author":"Mokhtar","year":"2012","journal-title":"Cancer"},{"key":"ref01","first-page":"617","article-title":"Tumor markers In editors Tietz textbook of clinical chemistry and molecular diagnostics th ed Philadelphia PA","author":"Sokoll","year":"2012"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1258\/acb.2011.011117","article-title":"The National Institute for Health and Clinical Excellence guidelines for early detection of ovarian cancer : the pivotal role of the clinical laboratory","author":"Sturgeon","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"ref241","first-page":"125","article-title":"The effect of the menstrual cycle on serum CA levels a population study","author":"Grover","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/CCLM.1998.024","article-title":"Need for correct estimates of biological variation : the example of reactive protein","author":"Franzini","year":"1998","journal-title":"Clin Chem Lab Med"},{"key":"ref121","first-page":"413","article-title":"Biologic variability of reactive protein is the available information reliable","author":"Braga","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref81","first-page":"125","article-title":"Assessment of biological variation and analytical imprecision of CA TPA in relation to monitoring of ovarian cancer","author":"Tuxen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"ref351","first-page":"4","article-title":"Serum human epididymis protein vs carbohydrate antigen for ovarian cancer diagnosis : a systematic","author":"Ferraro","year":"2013","journal-title":"review J Clin Pathol"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/000456329703400103","article-title":"Proposal for setting generally applicable quality goals solely based on biology","volume":"34","author":"Fraser","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"ref311","first-page":"617","article-title":"Tumor markers In editors Tietz textbook of clinical chemistry and molecular diagnostics th ed Philadelphia PA","author":"Sokoll","year":"2012"},{"key":"ref461","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/20.12.1535","article-title":"Effects of intra - and inter - individual variation on the appropriate use of normal range","volume":"20","author":"Harris EK","year":"1974","journal-title":"Clin Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref321","article-title":"National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular prostate colorectal breast and ovarian cancers","volume":"11","author":"Sturgeon","year":"2008","journal-title":"Clin Chem"},{"key":"ref571","first-page":"206","article-title":"Serum levels of the ovarian cancer biomarker are decreased in pregnancy and increase with age","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref291","first-page":"125","article-title":"Reference ranges for HE CA in a large Asian population by automated assays and diagnostic performances for ovarian cancer","author":"Park","year":"2012","journal-title":"Int J Cancer"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/000456329102800301","article-title":"PH The importance of imprecision","volume":"28","author":"Fraser","year":"1991","journal-title":"Ann Clin Biochem"},{"key":"ref331","article-title":"National Institute for Health and Clinical Excellence Guidance Ovarian cancer : the recognition and initial management of ovarian cancer National Collaborating Centre for Cardiff National Collaborating Centre for","author":"NICE","year":"2011","journal-title":"Cancer Cancer"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref251","first-page":"6391","article-title":"Human epididymis protein reference intervals in a multiethnic Asian women population Asian","volume":"13","author":"Mokhtar","year":"2012","journal-title":"Cancer"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1258\/acb.2011.011117","article-title":"The National Institute for Health and Clinical Excellence guidelines for early detection of ovarian cancer : the pivotal role of the clinical laboratory","author":"Sturgeon","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"ref521","first-page":"1","article-title":"Desirable specifications for total error imprecision and bias derived from intra - and inter - individual biologic variation Available from http www westgard com biodatabase htm format phocapdf Accessed","author":"January","year":"2014"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0004563213500657","article-title":"Is serum human epididymis protein ready for prime time","author":"Ferraro","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"ref11","article-title":"National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular prostate colorectal breast and ovarian cancers","volume":"11","author":"Sturgeon","year":"2008","journal-title":"Clin Chem"},{"key":"ref131","first-page":"166","article-title":"Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women","author":"Tamimi","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2004.040659","article-title":"de Biological variation of tumor markers and its application in the detection of disease progression in patients with non - small cell lung cancer","volume":"22","author":"Trap\u00e9","year":"2005","journal-title":"Clin Chem"},{"key":"ref71","first-page":"89","article-title":"Objective interpretation of results for tumour marker Allied","author":"Browning","year":"1990","journal-title":"J Nucl Med Sci"},{"key":"ref391","first-page":"125","article-title":"Assessment of biological variation and analytical imprecision of CA TPA in relation to monitoring of ovarian cancer","author":"Tuxen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"ref261","first-page":"206","article-title":"Serum levels of the ovarian cancer biomarker are decreased in pregnancy and increase with age","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0004563213500657","article-title":"Is serum human epididymis protein ready for prime time","author":"Ferraro","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"ref31","first-page":"125","article-title":"Potential markers that complement expression of CA in epithelial ovarian cancer","author":"Rosen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref341","first-page":"125","article-title":"Potential markers that complement expression of CA in epithelial ovarian cancer","author":"Rosen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/000456329703400103","article-title":"Proposal for setting generally applicable quality goals solely based on biology","volume":"34","author":"Fraser","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"ref151","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/20.12.1535","article-title":"Effects of intra - and inter - individual variation on the appropriate use of normal range","volume":"20","author":"Harris EK","year":"1974","journal-title":"Clin Chem"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.2012.43.6691","article-title":"CD Longitudinal screening algorithm that incorporates change over time in CA levels identifies ovarian cancer earlier than a single - threshold rule","volume":"31","author":"Drescher","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2014-0097\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T12:30:42Z","timestamp":1650285042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2014-0097\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,19]]},"references-count":56,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2014-0097","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,19]]}}}